C07D 309/12
Only hydrogen atoms and one oxygen atom directly attached to ring carbon
Official title: only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
C07D309/12 (Only hydrogen atoms and one oxygen atom directly attached to ring carbon) appears on 1,128 US grants and 434 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,128
- Published applications
- 434
- Assignees
- 375
- Inventors
- 2,117
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 76 | 0 |
| 1977 | 74 | 0 |
| 1978 | 144 | 0 |
| 1979 | 48 | 0 |
| 1980 | 58 | 0 |
| 1981 | 42 | 0 |
| 1982 | 39 | 0 |
| 1983 | 35 | 0 |
| 1984 | 30 | 0 |
| 1985 | 19 | 0 |
| 1986 | 12 | 0 |
| 1987 | 12 | 0 |
| 1988 | 17 | 0 |
| 1989 | 20 | 0 |
| 1990 | 14 | 0 |
| 1991 | 14 | 0 |
| 1992 | 8 | 0 |
| 1993 | 13 | 0 |
| 1994 | 16 | 0 |
| 1995 | 15 | 0 |
| 1996 | 15 | 0 |
| 1997 | 25 | 0 |
| 1998 | 21 | 0 |
| 1999 | 13 | 0 |
| 2000 | 9 | 0 |
| 2001 | 15 | 4 |
| 2002 | 19 | 18 |
| 2003 | 16 | 23 |
| 2004 | 18 | 27 |
| 2005 | 7 | 18 |
| 2006 | 9 | 18 |
| 2007 | 6 | 14 |
| 2008 | 16 | 16 |
| 2009 | 13 | 20 |
| 2010 | 13 | 17 |
| 2011 | 17 | 16 |
| 2012 | 12 | 24 |
| 2013 | 13 | 23 |
| 2014 | 18 | 12 |
| 2015 | 22 | 28 |
| 2016 | 16 | 22 |
| 2017 | 24 | 16 |
| 2018 | 13 | 15 |
| 2019 | 17 | 13 |
| 2020 | 7 | 19 |
| 2021 | 11 | 17 |
| 2022 | 10 | 12 |
| 2023 | 7 | 13 |
| 2024 | 5 | 11 |
| 2025 | 6 | 8 |
| 2026 | 9 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Griseofulvin compound and pharmaceutical use thereof28 Jul 2026US 12,692,258 B2Daiichi Sankyo Company, Limited
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Afibrotic compounds, devices, and uses thereof21 Apr 2026US 12,605,486 B2Sigilon Therapeutics, Inc.
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Endocannabinoid ligands and related analogs13 Aug 2026US 2026/0234099 A1Northeastern University
- Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, pattern forming method, and method for producing electronic device9 Jul 2026US 2026/0194813 A1FUJIFILM Corporation
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Systems and methods for the synthesis of hydroxamic acids5 Mar 2026US 2026/0062400 A1Kennesaw State University Research and Service Foundation, Inc.
Most cited
By later US patents
- Phenethanolamine derivatives172US 4,992,474 AGlaxo Group Limited · 1991
- Composition and process140US 4,306,075 AThe Upjohn Company · 1981
- Antiretroviral enantiomeric nucleotide analogs124US 6,057,305 AInstitute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic · 2000
- 3-Hydroxybutyric acid polymers114US 4,427,614 AImperial Chemical Industries PLC · 1984
- Antiretroviral enantiomeric nucleotide analogs113US 6,653,296 B1Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic · 2003